![Scott Somma](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Scott Somma worked as a Director at Albany Molecular Research Ltd.
from 2017 to 2018.
He also served as a Co-Managing Director at Curia Germany GmbH.
Ehemalige bekannte Positionen von Scott Somma
Unternehmen | Position | Ende |
---|---|---|
Albany Molecular Research Ltd.
![]() Albany Molecular Research Ltd. Pharmaceuticals: MajorHealth Technology Albany Molecular Research Ltd. manufactures pharmaceutical products. The company was founded on February 16, 2004 and is headquartered in Bristol, the United Kingdom. | Direktor/Vorstandsmitglied | 28.12.2018 |
Curia Germany GmbH
![]() Curia Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Curia Global, Inc., Curia Germany GmbH is a company that specializes in Active Pharmaceutical Ingredients & Intermediates. The company is based in Frankfurt, Germany. The company provides quality products, reliably and responsibly applying the world's most difficult chemical technologies. The company was founded in 2006 and the CEOs are Joachim Kaus and Thomas Randall. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Albany Molecular Research Ltd.
![]() Albany Molecular Research Ltd. Pharmaceuticals: MajorHealth Technology Albany Molecular Research Ltd. manufactures pharmaceutical products. The company was founded on February 16, 2004 and is headquartered in Bristol, the United Kingdom. | Health Technology |
Curia Germany GmbH
![]() Curia Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Curia Global, Inc., Curia Germany GmbH is a company that specializes in Active Pharmaceutical Ingredients & Intermediates. The company is based in Frankfurt, Germany. The company provides quality products, reliably and responsibly applying the world's most difficult chemical technologies. The company was founded in 2006 and the CEOs are Joachim Kaus and Thomas Randall. | Health Technology |